During the past decade, Axcess Medical Research, LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Axcess Medical Research, LLC" are "Cerebral Palsy" (4 trials), "Muscle Spasticity" (4 trials), "Pediatrics" (4 trials), "Leiomyoma" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "Axcess Medical Research, LLC" in a lesser frequency.

Most popular intervention types in "Axcess Medical Research, LLC" are "Biological" (4 trials), "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum Toxin Type A" (2 trials), "Normal Saline (Placebo)" (2 trials), "Vilaprisan (BAY1002670)" (2 trials), "botulinum toxin Type A" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Axcess Medical Research, LLC" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Axcess Medical Research, LLC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Axcess Medical Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Axcess Medical Research, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".